Phase 1/2 trial of Carfilzomib plus High Dose Melphalan Preparative Regimen for Salvage AHCT Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myelo...

Tekijä Costa, Luciano J., Landau, Heather J., Chhabra, Saurabh, Hari, Parameswaran, Innis-Shelton, Racquel, Godby, Kelly N, Hamadani, Mehdi, Tamari, Roni, Anderton, Kate, Dixon, Pamela, Giralt, Sergio A.
Julkaisussa Biol Blood Marrow Transplant (2018)

Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features

Tekijä VanValkenburg, MaryAnn E., Pruitt, Gwendolyn I., Brill, Ilene K., Costa, Luciano, Ehtsham, Maryam, Justement, Ian T., Innis-Shelton, Racquel D., Salzman, Donna, Reddy, E. Shyam P., Godby, Kelly N., Mikhail, Fady M., Carroll, Andrew J., Reddy, Vishnu B., Sanderson, Ralph D., Justement, Louis B., Sanders, Paul W., Brown, Elizabeth E.
Julkaisussa Cancer Causes Control (2015)

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma

Tekijä Cornell, Robert F., D’ Souza, Anita, Kassim, Adetola A., Costa, Luciano J., Innis-Shelton, Racquel D., Zhang, Mei-Jie, Huang, Jiaxing, Abidi, Muneer, Aiello, Jack, Akpek, Gorgun, Bashey, Asad, Bashir, Qaiser, Cerny, Jan, Comenzo, Raymond, Diaz, Miguel Angel, Freytes, César, Gale, Robert Peter, Ganguly, Siddhartha, Hamadani, Mehdi, Hashmi, Shahrukh, Holmberg, Leona, Hossain, Nasheed, Kamble, Rammurti T., Kharfan-Dabaja, Mohamed, Kindwall-Keller, Tamila, Kyle, Robert, Kumar, Shaji, Lazarus, Hillard, Lee, Cindy, Maiolino, Angelo, Marks, David I., Meehan, Kenneth, Mikhael, Joe, Nath, Rajneesh, Nishihori, Taiga, Olsson, Richard F., Ramanathan, Muthalagu, Saad, Ayman, Seo, Sachiko, Usmani, Saad, Vesole, David, Vij, Ravi, Vogl, Dan, Wirk, Baldeep M., Yared, Jean, Krishnan, Amrita, Mark, Tomer, Nieto, Yago, Hari, Parameswaran
Julkaisussa Biol Blood Marrow Transplant (2016)